Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for PRETOMANID
- Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis
- Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
- Phase 2 Trial Assessing TBAJ876 or Bedaquiline, With Pretomanid and Linezolid in Adults With Drug-sensitive Pulmonary Tuberculosis
- Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis
- A Pan-TB Regimen Targeting Host and Microbe
- Study of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children With Rifampicin-Resistant Tuberculosis
- BPaL Regimen in FQ Resistant MDR-TB
- Modified BPaL Regimen for Managing Pre-XDR TB and MDR (TI/NR) TB in India
- A Study in Two Panels of Healthy Adult Participants to Assess Single-Dose Immediate-Release and Single-Dose Dispersible Formulations of Pretomanid
- Economic Evaluation of New MDR TB Regimens
- A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant (DR-TB) Pulmonary TB Volunteers (PaSEM)
- PRACTECAL-PKPD Sub Study
- Patient-reported Experiences and Quality of Life Outcomes in the TB-PRACTECAL Clinical Trial
- Single-Dose Study to Evaluate the PKs of Pretomanid in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function
- Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients
- Safety and Efficacy of Various Doses and Treatment Durations of Linezolid Plus Bedaquiline and Pretomanid in Participants With Pulmonary, XDR-TB, Pre- XDR-TB or Non-responsive/Intolerant MDR-TB (ZeNix)
- Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s)
- Pretomanid in Adults With Hepatic Impairment
- A Phase 3 Study Assessing the Safety and Efficacy of Bedaquiline Plus PA-824 Plus Linezolid in Subjects With Drug Resistant Pulmonary Tuberculosis
- Assessing PA-824 for Tuberculosis (the APT Trial)
- Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
Clinical trials list
click for details